TEAM Technologies a leading end-to-end outsourced manufacturer of mission-critical medical devices, today announced the acquisition of Duke Empirical, Inc. (“Duke”), a premier designer, developer, and manufacturer of innovative medical devices focused on advanced catheters and minimally invasive delivery systems. This acquisition marks a significant expansion of TEAM Tech’s capabilities in the minimally invasive, cardiology, and interventional markets, providing customers with a fully integrated, turnkey solution that combines Duke’s specialized front-end design and catheter expertise with TEAM Tech’s comprehensive capability set and global manufacturing footprint.

Based in Morgan Hill, CA., Duke is recognized for its deep technical expertise and innovation in catheter design, complex medical extrusion, and high precision assembly. The company serves top-tier global OEMs with a differentiated suite of capabilities, proprietary technologies, and a state-of-the-art facility. Specifically, Duke manufactures a variety of catheters, including those used for minimally invasive structural heart, cardiovascular, neurovascular, urology, and kidney-related procedures, while offering custom design and development services for catheter-based medical devices including guide catheters, balloon dilation catheters, and ultrasound catheters.

“This is a pivotal step in our strategy to become the full-service partner of choice for healthcare OEMs in high-growth, high-acuity end markets,” commented Marshall White, President and CEO of TEAM Tech. “With Duke’s complementary capabilities and innovative solutions, we are expanding the breadth and depth of services we offer to our partners while advancing our mission of Helping Those Who Help Others.”

Duke’s devices play a critical role in minimally invasive procedures, particularly in interventional and structural heart applications. Its advanced catheter systems, including custom and steerable designs, enable clinicians to navigate complexity and deliver therapies with precision in high-risk cardiovascular interventions. These mission-critical components improve access, efficiency, and outcomes in life-saving procedures, making Duke’s technologies foundational to the development of next-generation therapies.

“We’re thrilled to bring our expertise in minimally invasive device design, development, and manufacturing to TEAM Tech’s platform,” said Robert LaDuca, Duke’s Founder and CEO. “This partnership gives us the scale, talent, and infrastructure to continue driving innovation and improve outcomes for patients worldwide.”

Houlihan Lokey served as financial advisor and Goodwin Procter LLP served as legal advisor to TEAM Tech and Arlington Capital Partners.

 

Source: businesswire.com

Report Abuse